KR20020041366A - A development of the effective functional nutrition supplement, 'SAGRAQUEEN' with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises - Google Patents

A development of the effective functional nutrition supplement, 'SAGRAQUEEN' with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises Download PDF

Info

Publication number
KR20020041366A
KR20020041366A KR1020020018346A KR20020018346A KR20020041366A KR 20020041366 A KR20020041366 A KR 20020041366A KR 1020020018346 A KR1020020018346 A KR 1020020018346A KR 20020018346 A KR20020018346 A KR 20020018346A KR 20020041366 A KR20020041366 A KR 20020041366A
Authority
KR
South Korea
Prior art keywords
intestines
weight
body fat
improving
constipation
Prior art date
Application number
KR1020020018346A
Other languages
Korean (ko)
Inventor
이성희
최애진
Original Assignee
이성희
주식회사 아미노젠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이성희, 주식회사 아미노젠 filed Critical 이성희
Priority to KR1020020018346A priority Critical patent/KR20020041366A/en
Publication of KR20020041366A publication Critical patent/KR20020041366A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/20—Natural extracts
    • A23V2250/21—Plant extracts
    • A23V2250/2102—Aloe

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE: A health food product containing kelp, Aloe arborescens, Plantago asiatica L., cascara sagrada, magnesium oxide or the like is provided. It has an effect on reducing body fat without substantive side effects such as stomachache, diarrhea or the like by improving a bowel movement and removing fecal impaction. CONSTITUTION: This functional food product comprises 40% by weight of kelp, 22% by weight of Aloe arborescens Mill. var. natalensis Berg., 17.5% by weight of Plantago asiatica L., 12% by weight of cascara sagrada, 3.5% by weight of magnesium oxide, 2.5% by weight of magnesium stearate and 2.5% by weight of lactic acid bacteria.

Description

장운동 개선 및 숙변 제거로 인한 체지방 감소에 효과적인 기능성 영양보충용 식품 '사그라퀸'의 개발의 제조{A development of the effective functional nutrition supplement, 'SAGRAQUEEN' with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises}A development of the effective functional nutrition supplement, 'SAGRAQUEEN' with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises}

· 본 발명은 알로에, 다시마, 차전자, 카스카라 사그라다, 유산균 등의 천연물질을 일정비율로 혼합하여 만성적인 변비 치료 및 숙변 제거, 장운동 개선, 체지방 감소에 도움을 줄 수 있는 기능성 영양보충용 식품 '사그라퀸'의 제조 방법에 관한 것입니다.The present invention is a functional nutritional supplement that can help to treat chronic constipation, elimination of stool, improve bowel movements, and reduce body fat by mixing natural ingredients such as aloe, kelp, chacha, cascara sagrada, lactic acid bacteria at a certain ratio It's about how to make sagraquin.

· 최근 한국인 특히 젊은이들의 식생활이 서구화 되어가고 있고 도시화 및 산업화에 따른 스트레스가 쌓임에 따라 변비현상을 비롯한 위장장해를 호소하는 사람들이 늘어나고 있다. 특히 젊은 여성층에는 변비를 호소하는 사람들이 상당수 있는 것으로 알려져 있다.Recently, as Koreans, especially young people, have become westernized and the stress of urbanization and industrialization has increased, more people are complaining of constipation and gastrointestinal disorders. Young women in particular are known to have a large number of people who complain of constipation.

· 변비란 건강할 때에 비하여 변이 굳고 건조하며 배변의 횟수나 양이 감소하여 불쾌감이나 생리적 장애를 수반하는 증상을 말한다. 배변의 횟수나 양에는 개인적 차이가 있으며 이들은 습관성 변비와 일과성 변비로 나누기도 한다. 변비의 원인으로는 식생활 습관, 생활환경의 변화, 체질, 정신적인 스트레스, 질병, 약의 남용 등을 들 수 있다.Constipation refers to symptoms that are associated with unpleasant feelings or physiological disorders due to a decrease in the number and amount of bowel movements. There are individual differences in the number and amount of bowel movements, which can be divided into habitual constipation and hot constipation. Constipation can include eating habits, changes in living conditions, constitution, mental stress, illness, and drug abuse.

· 변비인구는 세계적으로 약 8∼20%, 국내에서는 약 10%를 차지한 만큼 보편화 됐으며 여성과 노인층에서 발병률이 높은 것으로 알려졌다. 우리나라 초등학교 학생을 대상으로 한 조사에서는 매일 1회 변을 보지 않는 사람이 42%나 된다 하였고 농촌 지역보다는 도시지역 아동에서 더 많았다. 한편 일본에서의 조사보고를 보면 남자 10.2%, 여자 37.4%였으며 18∼24세의 젊은 여성에게서 특히 많았다.(강국희, 허경택.비피더스균과 올리고당.유한문화사)Constipation population is about 8-20% in the world and about 10% in Korea, so it is generalized and the incidence rate is high among women and the elderly. In a survey of elementary school students in Korea, 42% of children did not see the stool once a day, more in urban children than in rural areas. Meanwhile, survey reports in Japan showed that 10.2% were male and 37.4% were female, especially among young women aged 18-24 (Kang Kuk-hee, Heo Kyung-taek, Bifidobacteria, Oligosaccharide, and Yuhan Culture History)

· 건강한 사람의 경우 섭취한 음식물이 장내에 체류하는 시간은 보통 8∼24시간. 그러나 장기능 장애를 가진 사람은 심지어 200시간까지 소요될 정도로 체류시간이 길다. 이 과정에서 장내 이상발효와 부패에 의해 페놀, 인돌, 아민, 포름알데히드, 암모니아 등 발암물질과 노화를 촉진하는 유해산소가 생성되고, 이 독소는 혈액을 타고 여러 장기에 흘러 들어가 각종 기능장애를 유발한다.Healthy people usually have 8 to 24 hours of food in their gut. However, people with bowel dysfunction have long residence times, even up to 200 hours. In this process, intestinal abnormal fermentation and decay produce carcinogens such as phenol, indole, amine, formaldehyde, and ammonia and harmful oxygen that promotes aging, and these toxins flow into the blood and cause various functional disorders. do.

· 소련의 생물학자 메치니코프박사는 변비 때문에 많은 병이 발생한다는 사실을 밝혀 냈습니다. 건강한 사람도 보통 1∼5kg 정도 심한 사람은 10∼12kg까지 장 속에 숙변이 정체되어 있으며, 이유없는 부스럼, 여드름, 기미, 주근깨 등과 같이 피부가 거칠어지는 것, 말초혈관의 혈액순환 장애로 두통이 잦은 것, 만성병에 약의 효과가 저하되는 것 모두 숙변 때문이라고 설명했다Soviet biologist Dr. Mechinnikov has revealed that constipation causes many illnesses. Healthy people usually have 1 ~ 5kg severe people up to 10 ~ 12kg in the intestines stagnated in the intestine, skin roughness, such as unexplained swelling, acne, blemishes, freckles, blood circulation of the peripheral blood vessels frequent headaches And the lowering of the drug's effectiveness in chronic disease are all explained by stool

· 현재 다양한 종류의 변비 치료 및 개선에 관련된 제품들이 시장에 많이나와 있으나 복통, 설사 등의 부작용이나 복용 후의 변비 개선의 근본문제를 해결하지 못하고 있어서 제품의 신뢰성이 떨어지고 있다.Currently, there are many products related to the treatment and improvement of various kinds of constipation in the market, but the side effects such as abdominal pain and diarrhea or the fundamental problem of constipation improvement after taking are not being reliable.

· 따라서 본 발명의 목적은 장운동 개선 및 숙변 제거로 인한 체지방 감소에 효과적인 효과적인 것으로 보고된 다시마, 알로에 아보레센스, 차전자피, 카스카라 사그라다의 특성을 이용하여 변비 개선 효과가 입증된 갭슐 형태의 건강식품을 제공하는 데 있다.Therefore, an object of the present invention is a capsule-type health food that has been proven to improve constipation by using the characteristics of kelp, aloe aboresce, chajeonpi, and cascara sagrada, which have been reported to be effective in reducing body fat due to improving bowel movement and eliminating stool. To provide.

· 또한 본 발명은 장운동 촉진 작용 및 숙변 제거로 인한 체지방 감소의 효과를 가져오는 생약성분으로 제조하여 복통, 설사 등의 부작용과 장기간복용시 변비 개선의 효과가 감소되는 것을 방지할 수 있는 건강식품으로 변비 치료 등의 도움을 받고자 하는 사람들에게 유용하게 사용될 것이다.In addition, the present invention is a health food that can prevent the reduction of side effects such as abdominal pain, diarrhea, and constipation improvement during long-term use by preparing a herbal ingredient that has the effect of reducing the body fat due to the promotion of bowel movement and elimination of stool It will be useful for people who want to get help with constipation.

· 본 발명으로 개발된 장운동 개선 및 숙변 제거로 인한 체지방 감소에 효과적인 기능성 영양보충용 식품 '사그라퀸'을 사용하여 임상실험을 실시한 결과 변비 증상이 개선되었고, 숙변제거로 인한 체지방량, 체지방율, 복부지방율 등이 감소함으로써 그 효과를 입증하였다.Clinical trials using functional food supplement Sagraquin, which is effective for improving intestinal motility and elimination of stool due to the present invention, resulted in improved constipation symptoms, body fat mass, body fat rate and abdominal fat rate. The effect was demonstrated by decreasing back.

· 도 1은 본 발명의 장운동 개선 및 숙변 제거로 인한 체지방 감소에 효과적인 기능성 영양보충용 식품 '사그라퀸'의 제조공정을 도시한 블록도이다.1 is a block diagram showing the manufacturing process of the functional nutritional supplement food 'sagraquine' effective for reducing the body fat due to the improvement of intestinal motility and elimination of stool.

· 도 2는 본 발명의 장운동 개선 및 숙변 제거로 인한 체지방 감소에 효과적인 기능성 영양보충용 식품 '사그라퀸' 임상실험에서 변비 증상 설문지 결과이다.Figure 2 is a result of the constipation symptom questionnaire in a functional nutritional food 'sagraquin' clinical trial effective in reducing the body fat due to the improvement of bowel movement and elimination of bowel movements of the present invention.

· 본 발명의 상기 목적과 특징은 다음의 상세한 설명에 의해 더욱 명확하게 이해할 수 있다.The above objects and features of the present invention can be more clearly understood by the following detailed description.

· 본 발명은 분말 형태의 다시마 40%, 알로에 아보레센스 22%, 차전자피 17.5%, 카스카라 사그라다 12%를 칭량하여 혼합기에서 균일하게 혼합한 다음 캡슐에 450mg씩 충진하여 제조한다.The present invention is prepared by weighing 40% of kelp in powder form, 22% of aloe aborescens, 17.5% of chaff and 1% of cascara sagrada, uniformly mixing in a mixer, and then filling the capsule with 450 mg.

· 본 발명품에 함유된 다시마, 알로에 아보레센스, 차전자피, 카스카라 사그라다 등 각각의 구성물의 기능, 효과적 측면을 기술하면 다음과 같다.Functions and effective aspects of each component, such as kelp, aloe aboresense, charcoal bar, and cascara sagrada contained in the present invention are described as follows.

· 다시마 속의 알긴산은 소화효소로 분해되지 않는 성분으로 음식물이 장속에 머무르는 시간을 단축하여 노폐물의 배출을 원활하게 해줍니다. 식이섬유는 대장의 운동을 촉진시켜 변의 장 통과 시간을 단축시키며, 배변량을 증가시킵니다.· Alginic acid in kelp is a component that is not broken down by digestive enzymes, which shortens the time for food to stay in the intestines and facilitates the discharge of waste products. Dietary fiber accelerates the movement of the large intestine, shortens the time to pass bowel bowel movements and increases bowel movements.

· 알로에 아보레센스 안의 안트로퀴논(anthroquinone) 유도체는 장의 운동을 도와 통변, 완하 작용을 나타내어 위와 장의 건강에 도움을 줍니다.Anthroquinone derivatives in aloe aboressen help the bowel movements to help with bowel movement and bowel movements.

· 차전자피는 부피가 크게 팽창하여 장벽에 붙은 불순물을 배설시켜 묵은 변을 없애고 배설물을 깨끗이 배설시키므로 변의 양이 늘어나게 됩니다. 또한 장관 벽에 작용하여 연동운동을 촉진시켜 대장의 운동리듬을 되살려 주며, 배설하기에 알맞은 변의 크기를 유지해 준다.· The carcass blood expands greatly in volume to excrete impurities attached to the barrier to get rid of old stools and to clean up excreta cleanly, thus increasing the amount of stools. It also acts on the intestinal wall, promoting peristalsis, reviving the movement rhythm of the large intestine, and maintaining the size of the sides suitable for excretion.

· 카스카라 사그라다는 수피의 안은 안트라퀴논 글리코사이드라 불리우는 성분이 연동운동을 초래하면서 대장의 수축작용을 자극하여 완화제로서 매우 효과적이다. 카스카라는 불량한 배변기능과 가스찬데, 소화불량, 식욕부진으로 인한 간장애, 대장염, 치핵을 치료하는데 유용하다.Cascara sagrada is very effective as an emollient by stimulating the contraction of the large intestine while a component called anthraquinone glycoside causes peristalsis. Cascara is useful for the treatment of poor bowel function and cold gas, liver failure due to indigestion and anorexia, colitis and hemorrhoids.

· 본 발명의 기능성 영양보충용 식품 '사그라퀸'에 함유된 성분은 모두 생약재, 식품재료 및 식품으로 사용되는 것으로 복용 또는 섭취시 인체에 전혀 해롭지 않으며 그 안전성이 우수하다.All ingredients contained in the functional nutritional supplement food 'sagraquin' of the present invention are used as herbal medicines, food ingredients and foods, and are not harmful to the human body when taken or ingested, and have excellent safety.

· 본 발명의 숙변 제거 및 장운동 개선의 건강식품 '사그라퀸'의 실시예를 들면 다음과 같다.Examples of the health food 'sagraquin' for eliminating stool and improving bowel movement of the present invention are as follows.

[표 1] 성분 및 배합비율(단위 중량 %)TABLE 1 Ingredients and Blending Ratio (Unit Weight%)

· 상기의 목적을 달성하기 위하여 다시마, 알로에 아보레센스, 차전자피, 카스카라 사그라다 등의 변비 증상 개선에 효과적인 기능성 소재가 함유된 캡슐형태 건강식품의 제조방법을 설명하면 다음과 같다.In order to achieve the above object, a method of preparing a capsule-type health food containing a functional material effective for improving constipation symptoms such as kelp, aloe aborescens, cha bar, and cascara sagrada will be described.

1) 제 1 공정 : 원료검사1) First process: raw material inspection

제품에 사용되는 원료가 규격에 적합한지 검사한다. (수분측정, 성상, 중금속, 대장균 검사 등)Check that the raw materials used in the product meet the specifications. (Moisture measurement, appearance, heavy metal, E. coli test)

2) 제 2 공정 : 원료배합2) 2nd process: mixing raw materials

규격에 적합한 원료만을 엄선하여 [표1]의 성분 및 배합비율에 따라 원료를 칭량하여 배합한다.Only raw materials that meet the specifications are carefully selected and weighed and blended according to the ingredients and blending ratios in Table 1.

3) 제 3 공정 : 혼합3) 3rd process: mixing

혼합기를 이용하여 각 원료가 균일하게 혼합되도록 한다.Use a mixer to ensure that each raw material is mixed evenly.

4) 제 4 공정 : 충진4) 4th process: filling

캡슐에 배송노즐을 통하여 균일하게 혼합된 원료를 충진기로 충진하며, 이 때 충진량은 445±5mg으로 한다.Fill the capsules with a raw material mixed evenly through the delivery nozzle with a filling amount of 445 ± 5mg.

5) 제 5 공정 : 포장5) 5th Process: Packing

포장규격(450mg×180정)에 따라 포장한다.Pack according to the packaging standard (450mg × 180 tablets).

6) 제 6 공정 : 제품검사6) 6th Process: Product Inspection

제품이 규격에 맞도록 제조되었는지, 제조과정 중에 오염여부가 없는지 검사한다.Inspect the product to ensure it is manufactured to specifications and free of contamination during the manufacturing process.

· 또한 상기 본 발명의 1일 섭취량은 450mg 캡슐을 3정씩 아침, 저녁 공복에 음용수로 섭취한다.In addition, the daily intake of the present invention is taken as drinking water on an empty stomach in the morning and evening three tablets of 450mg each.

· 이하 본 발명의 실시예에 따른 변비 증상 개선 효과를 측정하기 위한 임상실험 방법과 그 결과를 제시한다.Hereinafter, the clinical trial method for measuring the effect of improving constipation symptoms according to an embodiment of the present invention and the results are presented.

[ 연구방법 ][Research method]

· 변비 증상이 많이 나타나는 수험생 및 직장인 여성 45명을 실험대상으로 하고, 변비증상이 없는 환자 5명은 대조군으로 하여 연구를 진행하였다. 본 발명의 장운동 개선 및 숙변 제거로 인한 체지방 감소에 효과적인 기능성 영양보충용 식품 '사그라퀸'을 30일 동안 아침, 저녁 공복에 3알씩 복용시키면서 변비 증상의 변화에 대하여 설문조사를 실시하였다.The subjects were 45 test takers and office workers who had many constipation symptoms, and 5 patients without constipation symptoms were used as controls. A questionnaire was carried out for the change of constipation symptoms while taking three tablets on an empty stomach in the morning and evening for 30 days for a functional nutritional supplement food 'sagraquin' effective for reducing the body fat due to the improvement of bowel movement and elimination of stool.

· 본 발명의 장운동 개선 및 숙변 제거로 인한 체지방 감소에 효과적인 기능성 영양보충용 식품 '사그라퀸'을 복용함으로써 체성분에 미치는 영향을 알아보고자 inbody 체성분 측정기를 이용하여 신체의 지방율, 복부지방율, 체중, BMI등의 항목을 조사하여 복용 전과 복용 후의 변화를 살펴보았다.Body fat rate, abdominal fat rate, body weight, body weight using the inbody body composition analyzer to find out the effect on the body composition by taking a functional nutritional supplement food 'sagraquin' effective for improving the bowel movement and elimination of stool Items such as BMI were examined to see changes before and after taking.

[ 연구결과 ][ Results ]

· 본 발명의 장운동 개선 및 숙변 제거로 인한 체지방 감소에 효과적인 기능성 영양보충용 식품 '사그라퀸' 복용 후 변비 증상에 대한 설문지 결과 대변보는 횟수가 하루에 한 번 정도라고 대답하는 실험자가 20% 정도로 증가하였습니다. 대변보는 소요시간이 10∼20분 정도에서 5∼10분, 5분 이하로 많이 짧아졌으며, 대변을 보는 실패 횟수도 많이 감소하였다. 배변시 통증감도 거의 없었지거나 한 달에 한 번 정도로 그 빈도수가 많이 감소하였으며, 잔변감의 빈도수 역시 많이 감소하는 결과를 나타내었습니다. 또한 배변시 힘든 정도의 빈도수도 한 달에 한 번 이하나 2-3회 정도로 감소하여 확실한 변비 개선 효과를 확인할 수 있었다.(그림 2)The results of the questionnaire on constipation symptoms after taking 'sagraquin', a functional supplement food that is effective for reducing body fat due to the improvement of bowel movement and elimination of stool, according to the present invention, increased by 20%. . Stool was shortened from 10 to 20 minutes to 5 to 10 minutes and less than 5 minutes, and the number of stool failures was also significantly reduced. The frequency of pain in the bowel movements was little or once a month, and the frequency decreased significantly, and the frequency of residual feelings also decreased. In addition, the frequency of difficulty in defecation was also reduced to less than once a month or 2-3 times, confirming the improvement of constipation (Figure 2).

· 체지방, 체지방율, 복부지방율은 표 2와 같이 '사그라퀸' 복용 전에 비하여 복용 후에 유의적으로(P<0.05) 감소하였으며, 체지방은 평균적으로 17.4Kg에서15.Kg으로 약 2Kg 정도 감소하였고, 체지방율은 29.3%에서 27.2%로 복부지방율은 0.83에서 0.81로 감소하였다.Body fat, body fat percentage and abdominal fat percentage were significantly decreased (P <0.05) after taking as compared to before taking sagraquin as shown in Table 2.Body fat decreased on average about 2Kg from 17.4Kg to 15.Kg, Body fat percentage decreased from 29.3% to 27.2% and abdominal fat decreased from 0.83 to 0.81.

[표 2] 체지방 분석 결과[Table 2] Body fat analysis results

· 체중과 신체지수는 표 3과 같이 '사그라퀸'의 복용 전에 비하여 복용 후에 약간 감소하는 경향을 나타내었으나, 유의성은 없었다. 체중은 평균적으로 58.9Kg에서 56.6Kg으로 3Kg정도 감소하는 효과가 나타났으며, 신체지수는 22.4에서 21.6으로 감소하였다.Body weight and body index showed a tendency to decrease slightly after taking as compared to before taking sagraquin as shown in Table 3, but there was no significance. On average, body weight decreased by 5 kg from 58.9 kg to 56.6 kg, and body index decreased from 22.4 to 21.6.

[표 3] 체중과 신체지수 분석결과[Table 3] Analysis of weight and body index

· 본 발명품은 천연 기능성 소재의 안전성이 우수한 성분을 사용하여 제조된 것으로, 타제품 복용시에 수반되는 복통, 설사 등의 부작용과 지속적인 복용으로 인한 부작용 등의 위험이 적은 특수영양보충용 식품이다.The present invention is manufactured using ingredients that are excellent in safety of natural functional materials, and is a special nutritional supplement food having a low risk of side effects such as abdominal pain and diarrhea and other side effects caused by continuous use.

· 본 발명품은 식생활이 서구화 되어가고 도시화 및 산업화에 따른 스트레스가 쌓임에 따라 변비현상을 비롯한 위장장해를 호소하는 사람들, 특히 젊은 여성층의 숙변 제거 및 장운동 개선, 만성변비 치료에 효과적이다.The present invention is effective in treating stool removal, intestinal motility improvement and chronic constipation treatment of people who complain of constipation and gastrointestinal disorders, especially young women, as their diet becomes westernized and the stress of urbanization and industrialization accumulates.

· 따라서 본 발명품은 첫째, 장운동 개선 및 숙변제거로 인한 체지방 감소의 효과를 가진다.Therefore, the present invention firstly has the effect of reducing body fat due to improved bowel movement and elimination of stool.

· 둘째, 배변효과를 촉진하여 체중을 감소시켜 다이어트 및 신체 balance 유지에 효과가 있다.Second, it is effective in maintaining diet and body balance by promoting weight loss and reducing weight.

· 셋째, 특히 본 발명품의 체내 지방율 분해 성분으로 인하여 복부비만율이 높은 대상자들의 체지방율 감소 및 WHR(waist hip ratio)의 감소에 효과적이다.Third, the fat breakdown component of the present invention is particularly effective in reducing body fat and WHR (waist hip ratio) of subjects with high abdominal obesity.

Claims (1)

· 분말 형태의 다시마 40%, 알로에 아보레센스 22%, 차전자피 17.5%, 카스카라 사그라다 12%, 산화마그네슘 3.5%, 스테아린산 마그네슘 2.5%, 유산균 2,5%를 칭량하여 혼합기에서 균일하게 혼합한 다음 445±5mg 중량의 캡슐 형태로 제조하는 것을 특징으로 하며, 임상실험을 통하여 장운동 개선 및 숙변 제거로 인한 체지방 감소의 효과가 입증된 기능성 영양보충용 식품 '사그라퀸'의 제조방법Weigh 40% kelp in powder form, 22% aloe aboresense, 17.5% charcoal, 12% cascara sagrada, magnesium oxide 3.5%, magnesium stearate 2.5%, and lactic acid bacteria 2,5%, and mix them uniformly in a mixer. It is characterized in that the manufacturing in the form of capsules weighing 445 ± 5mg, the manufacturing method of functional nutrition supplement food 'sagraquin' proved the effect of reducing the body fat by improving bowel movement and elimination of stool through clinical trials
KR1020020018346A 2002-04-03 2002-04-03 A development of the effective functional nutrition supplement, 'SAGRAQUEEN' with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises KR20020041366A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020020018346A KR20020041366A (en) 2002-04-03 2002-04-03 A development of the effective functional nutrition supplement, 'SAGRAQUEEN' with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020020018346A KR20020041366A (en) 2002-04-03 2002-04-03 A development of the effective functional nutrition supplement, 'SAGRAQUEEN' with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises

Publications (1)

Publication Number Publication Date
KR20020041366A true KR20020041366A (en) 2002-06-01

Family

ID=19720182

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020020018346A KR20020041366A (en) 2002-04-03 2002-04-03 A development of the effective functional nutrition supplement, 'SAGRAQUEEN' with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises

Country Status (1)

Country Link
KR (1) KR20020041366A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030096615A (en) * 2002-06-17 2003-12-31 방성모 A composite and manufacture method distinguished constipation improvement effect

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950014655A (en) * 1993-11-10 1995-06-16 전성원 Hydraulic Engine Mount
KR19990084271A (en) * 1998-05-02 1999-12-06 서경배 Tea with improvement of constipation symptoms and its manufacturing method
US6245326B1 (en) * 1997-06-30 2001-06-12 Sigma Pharmaceuticals Pty. Ltd. Health supplement
KR20010096623A (en) * 2000-12-26 2001-11-08 강창환 The composites of fermented vegetable drinks possessing the function of cleaning the bowels and relieving constipation
KR20010103065A (en) * 2001-07-23 2001-11-23 박재금 Diet composition comprising dietary fiber
KR20030004993A (en) * 2002-03-29 2003-01-15 김용문 Method for manufacturing complex health fermented food on the base natural plant
KR20030046798A (en) * 2001-12-06 2003-06-18 박동기 The health-assisting food having improvement effects of constipation and intestines activity and its compositions

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950014655A (en) * 1993-11-10 1995-06-16 전성원 Hydraulic Engine Mount
US6245326B1 (en) * 1997-06-30 2001-06-12 Sigma Pharmaceuticals Pty. Ltd. Health supplement
KR19990084271A (en) * 1998-05-02 1999-12-06 서경배 Tea with improvement of constipation symptoms and its manufacturing method
KR20010096623A (en) * 2000-12-26 2001-11-08 강창환 The composites of fermented vegetable drinks possessing the function of cleaning the bowels and relieving constipation
KR20010103065A (en) * 2001-07-23 2001-11-23 박재금 Diet composition comprising dietary fiber
KR20030046798A (en) * 2001-12-06 2003-06-18 박동기 The health-assisting food having improvement effects of constipation and intestines activity and its compositions
KR20030004993A (en) * 2002-03-29 2003-01-15 김용문 Method for manufacturing complex health fermented food on the base natural plant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030096615A (en) * 2002-06-17 2003-12-31 방성모 A composite and manufacture method distinguished constipation improvement effect

Similar Documents

Publication Publication Date Title
KR101911205B1 (en) Composition for defecation inducement and diet and producing method thereof
CN110447902B (en) Composition with weight-losing effect
CN101579120A (en) Nutritional food with weight-losing function and preparation method thereof
CN108771239A (en) A kind of strengthening the spleen and stomach herbal paste and preparation method thereof
JPH03151854A (en) Composition for improving intestinal environment
CN104661680B (en) Compound and its influence to appetite control and insulin sensitivity
KR20070113460A (en) The health food composition for regulating weight
CN102613461B (en) Rapidly beautifying and weight losing nourishment and preparation method thereof
KR20010103065A (en) Diet composition comprising dietary fiber
Bortolotti et al. Effect of a balanced mixture of dietary fibers on gastric emptying, intestinal transit and body weight
CN110384743A (en) A kind of complex prebiotics chewable tablets inhibiting helicobacter pylori
CN103920140A (en) Compound preparation for reducing blood glucose, body weight and fat for human
CN102028138B (en) Composition for catharsis and preparation method thereof
KR20020041366A (en) A development of the effective functional nutrition supplement, &#39;SAGRAQUEEN&#39; with the effects of the decreasing body fat by removing feces contained long in the intestines and the improving intestines excises
CN116268414A (en) Composition for improving gastrointestinal function and preventing constipation and application thereof
CN101444598A (en) Traditional Chinese medicine composition for treating uremia and preparation method and use thereof
CN107647417A (en) Treat constipation and reduce nutraceutical of body fat and preparation method thereof
CN110327437B (en) Traditional Chinese medicine for treating chronic diarrhea and preparation method thereof
CN106237295A (en) A kind of sodium ascorbyl phosphate oral solution compositions and preparation method thereof
CN109757629A (en) A kind of compound yacon liquid meal composition and its preparation and application
CN1406624A (en) Medicinal composition with nourishing and tranquilizing
CN108497383A (en) A kind of traditional Chinese medicine health care preparation with fat-eliminating antihypelipidemic effect
CN100345570C (en) Health care product for treating intestine duct disease, preparation and use method thereof
CN109221903A (en) A kind of auxiliary defaecation and the meal replacement powder of norcholesterol and its preparation method and application
KR20010044542A (en) Health auxiliary food composition having effect for intestines function and food comprising same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application